Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)

NCT04186013 is registered in ClinicalTrials.gov with Spanish Oncology Genito-Urinary Group as lead sponsor.

NCT NCT04186013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04186013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)
Lead sponsor
Spanish Oncology Genito-Urinary Group
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 18, 2019
Completion date
May 31, 2027
Enrollment
39 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer